Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group

HTS Benamer, J Patterson, DG Grosset… - … : official journal of the …, 2000 - Wiley Online Library
OBJECTIVE: To evaluate whether visual assessment of [123I]-FP-CIT (DaTSCAN™, Nycomed
Amersham, plc) single photon emission computerized tomography (SPECT) images can …

[PDF][PDF] Consensus on microembolus detection by TCD

…, DW Droste, VL Babikian, DH Evans, DG Grosset… - Stroke, 1998 - academia.edu
Transcranial Doppler ultrasound is capable of detecting microembolic material, both gaseous
and solid, within the intracranial cerebral arteries. To avoid discrediting this promising and …

Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake

…, DM Hadley, GJA Macphee, DG Grosset - … : official journal of the …, 2000 - Wiley Online Library
The variability in clinical features and the masking effects of drug therapy in Parkinson's
disease (PD) can affect clinical assessment of disease severity. The aim of this study was to …

Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT

…, H Höffken, A Gerstner, DG Grosset - Movement …, 2009 - Wiley Online Library
Overdiagnosis of Parkinson's disease (PD) is suggested by specialist review of community
diagnosis, and in postmortem studies. In specialist centers 4 to 15% of patients entered into …

Role of dopamine transporter imaging in routine clinical practice

V Marshall, D Grosset - Movement disorders: official journal of …, 2003 - Wiley Online Library
Functional imaging of the dopamine transporter (DAT) defines integrity of the dopaminergic
system and has its main clinical application in patients with mild, incomplete, or uncertain …

Parkinson's disease age at onset genome‐wide association study: defining heritability, genetic loci, and α‐synuclein mechanisms

…, P Tienari, K Majamaa, M Toft, DG Grosset… - Movement …, 2019 - Wiley Online Library
Background Increasing evidence supports an extensive and complex genetic contribution to
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …

Suboptimal medication adherence in Parkinson's disease

KA Grosset, I Bone, DG Grosset - Movement disorders: official …, 2005 - Wiley Online Library
Patients take less medication than prescribed in many disease areas but evidence for
suboptimal therapy adherence in Parkinson's disease (PD) is limited. A single‐center …

Role of DAT‐SPECT in the diagnostic work up of parkinsonism

…, J Schwarz, A Antonini, D Grosset… - … : official journal of the …, 2007 - Wiley Online Library
The diagnosis of idiopathic Parkinson's disease (PD) can be achieved with high degrees of
accuracy in cases with full expression of classical clinical features. However, diagnostic …

Genome‐wide association studies of cognitive and motor progression in Parkinson's disease

…, L Hubbard, N Malek, KA Grosset… - Movement …, 2021 - Wiley Online Library
Background There are currently no treatments that stop or slow the progression of Parkinson's
disease (PD). Case–control genome‐wide association studies have identified variants …

Adherence to antiparkinson medication in a multicenter European study

D Grosset, A Antonini, M Canesi… - … : official journal of the …, 2009 - Wiley Online Library
Two small studies reported suboptimal therapy adherence in Parkinson's disease. We
conducted a larger multicenter European study to assess medicine‐taking behavior. Parkinson's …